glp-1 approved for sleep apnea Efficacy of Receptor agonists in treating Obstructive apnea: A systematic review and meta-analysis of cardiometabolic and respiratory outcomes glp-1 drugs for sleep apnea
Description
A GLP1 receptor agonist diabetes drug ameliorates neurodegeneration in a mouse model of infantile neurometabolic disease
List Of Sources Used In This Article American Heart Association Journals
Contrastingly, the body weight of rats in the T2DM + EX-4 group was stable and increased slowly (Figure 6A)
Share with Us
Barrington P, Chien JY, Showalter HD, et al
These findings are encouraging, and must be interpreted cautiously, as many studies cannot separate direct pharmacologic effects from improvements in metabolic health that accompany treatment
